Sort by
Refine Your Search
-
. Establishes new research protocols and procedures. Develops service line focused on peer support services participating in all aspects necessary to accomplish this goal. Develops projects focused on peer
-
/or research supervisors. Documents clinical activities. Evaluates and analyzes data independently. Establishes new research protocols and procedures. Develops service line focused on peer support
-
, metabolism, and the development and treatment of metabolic diseases such as obesity and cancer. The goal is to identify nutritional interventions and metabolic pathways for prevention and treatment
-
-procedural data collection, CTA measurements, and ultrasound interpretation. Develops clinical research studies and conducts data collection, data analysis and interpretation in advance aortic research within
-
translational research focuses on ligandomics, a new omics technology engineered by our group, for drug target discovery and novel therapy development to treat ocular diseases, including glaucoma, diabetic
-
translational research focuses on ligandomics, a new omics technology engineered by our group, for drug target discovery and novel therapy development to treat ocular diseases, including glaucoma, diabetic
-
translational research focuses on ligandomics, a new omics technology engineered by our group, for drug target discovery and novel therapy development to treat ocular diseases, including glaucoma, diabetic
-
are also developing novel machine learning methods to improve risk gene prediction and variant interpretation. This role will focus on the analysis of large-scale human genetics, scRNAseq, and proteomics
-
to numerous preclinical research projects focused on the development of novel molecular magnetic resonance imaging (MRI)-based techniques for early detection, disease phenotyping and monitoring treatment
-
will analyze microbiome and virome datasets (16S rRNA and WGS) from clinical samples and will develop and apply advanced analysis pipelines. The role also involves using next-generation human organoid co